What Do Leukoencephalopathy & Lipid Peak Mean on an SLS MRI?

When your child’s neurologist mentions “leukoencephalopathy” and a “lipid peak,” it can sound incredibly intimidating. In plain language, these terms describe the cause and effect of Sjögren-Larsson syndrome (SLS) inside your child’s brain. Leukoencephalopathy means there is damage to the brain’s white matter—the protective insulation around nerve fibers ^[1]. The lipid peak is a specialized chemical scan showing the underlying cause of this damage: a buildup of trapped fats (lipids) that the brain cannot break down ^[2]. Together, these two findings form a hallmark visual signature of SLS on diagnostic imaging.

Understanding Leukoencephalopathy

To understand leukoencephalopathy (pronounced loo-ko-en-sef-uh-LOP-uh-thee), it helps to break the word down: “leuko” means white, “encephalo” means brain, and “pathy” means disease. It simply refers to a condition affecting the brain’s white matter.

Think of the brain’s nerve pathways as electrical wires. To send signals quickly, these wires are coated in a protective fatty insulation called myelin ^[1]. In SLS, this myelin insulation is damaged or impaired ^[1]. On a standard MRI scan, this damage shows up as bright white patches known as “hyperintensities” ^[3].

Because the insulation is compromised, the brain’s electrical signals cannot travel smoothly. This disrupted communication is why children with SLS develop neurological symptoms like spasticity (tight, stiff muscles) and delays in motor skills ^[4][1]. It is also important to note that while this damage does not resolve, it typically does not undergo the rapid, severe degeneration seen in some other fatal white matter diseases, though symptoms do require lifelong management. Furthermore, while the disease heavily impacts the white matter, recent research shows it can also affect the brain’s gray matter, particularly the areas controlling movement ^[4].

The “Lipid Peak”: Seeing the Blockage

When the doctor mentions a lipid peak, they are referring to the results of a specialized type of imaging called Magnetic Resonance Spectroscopy (MRS). While a standard MRI takes pictures of the brain’s physical structure, an MRS measures the brain’s chemical makeup ^[2]. Fortunately, an MRS is usually performed at the exact same time as a standard MRI, meaning it does not require a separate appointment or additional sedation.

SLS is caused by a genetic mutation in the ALDH3A2 gene, which leaves the body deficient in an enzyme called FALDH ^[5]. Without this enzyme, the body cannot break down specific fatty molecules known as fatty alcohols and fatty aldehydes ^[6]. Instead of being cleared away normally, these toxic fats accumulate in the tissues, including the brain ^[7][6]. This exact same fat accumulation process is also what causes the severe dry, scaly skin (ichthyosis) that is characteristic of SLS ^[8].

When the MRS scanner measures the brain’s chemistry, it plots the different chemical levels on a graph. In a child with SLS, the scanner detects a significant accumulation of these trapped fats and records a sharp spike on the graph—specifically at a chemical marker of “1.3 ppm” ^[9][10].

This 1.3 ppm lipid peak serves as visual proof of those unmetabolized fats pooling in the brain’s white matter ^[10]. Because this peak is highly characteristic of the disease, neurologists use it as a powerful tool to help confirm an SLS diagnosis, alongside standard genetic testing for the ALDH3A2 gene ^[2].

A Crucial Note on Diet

Because SLS involves a “buildup of fats,” parents naturally wonder if they should restrict their child’s fat intake. It is critical to understand that this buildup is a metabolic issue caused by the missing FALDH enzyme ^[5]. The accumulation comes from the body’s internal inability to break down specific fatty aldehydes and alcohols, rather than from general dietary fat intake ^[6]. Therefore, attempting to manage this disease by restricting essential dietary fats is not standard practice for addressing the genetic enzyme deficiency and could unnecessarily deprive a developing child of necessary nutrition ^[5].

What This Means for Your Child

Seeing these exact terms on an MRI report confirms what your medical team suspects:

• The lipid peak confirms the underlying metabolic traffic jam, highlighting the buildup of unmetabolized fats ^[10].
• The leukoencephalopathy confirms the structural result, showing the damage to the myelin insulation caused by those fats ^[1][10].

Having this clear diagnostic picture helps your care team move forward. It allows them to coordinate the right specialists, confidently confirm the diagnosis, and focus on supportive physical therapies to manage spasticity and protect your child’s overall development.